Haixu Song

Title: Haixu Song: Innovator in Medical Applications of CREG Protein

Introduction

Haixu Song is a notable inventor based in Shenyang, China. He has made significant contributions to the field of medicine, particularly through his research and innovations related to the CREG protein. His work focuses on developing treatments for serious cardiovascular conditions.

Latest Patents

Haixu Song holds a patent for the medical use of Cellular Repressor of E1A-stimulated Genes (CREG). This invention pertains to the use of CREG protein or its active fragments in the manufacture of medicaments aimed at preventing and treating myocardial infarction. Additionally, it addresses ventricular remodeling after myocardial infarction and heart failure, as well as myocardial ischemia-reperfusion injury and salt-sensitive hypertensive myocardial fibrosis.

Career Highlights

Haixu Song is affiliated with the General Hospital of Chinese PLA Northern Theater Command. His role in this esteemed institution allows him to contribute to groundbreaking medical research and innovation. His dedication to improving patient outcomes through scientific advancements is commendable.

Collaborations

Some of his notable coworkers include Xiaolin Zhang and Meili Liu. Their collaborative efforts in research and development have further enhanced the impact of their work in the medical field.

Conclusion

Haixu Song's innovative work with CREG protein exemplifies the potential of scientific research to address critical health issues. His contributions are paving the way for new treatments that could significantly improve the quality of life for patients suffering from cardiovascular diseases.